Battle Over Herb-Induced Liver Injury: Low Prevalence Confirmed through Secondary Evaluation and Research Team's Clarifying Rebuttal to Unwarranted Public Claims
Restricted accessArticle commentaryFirst published online March, 2019
Battle Over Herb-Induced Liver Injury: Low Prevalence Confirmed through Secondary Evaluation and Research Team's Clarifying Rebuttal to Unwarranted Public Claims
LeeJ, ShinJS, KimMR, et al.Liver enzyme abnormalities in taking traditional herbal medicine in Korea: A retrospective large sample cohort study of musculoskeletal disorder patients. J Ethnopharmacol, 2015; 169:407–412.
2.
KimMS. Re-ignition of hepatic toxicity issue of herbal medicine… Debate over Jaseng Hospital of Korean Medicine research. Daily Medi. Online document at: http://dailymedi.com/detail.php?number=801944, accessed May27, 2018.
3.
LeeJY. Claim that ‘herbal medicine improves liver function’ of Korean medicine circles is ‘false.’ Medical news. Online document at: www.bosa.co.kr/news/articleView.html?idxno=598690, accessed May27, 2018.
4.
SongSC. Study that herbal medicine improves liver function ‘faulty from design’. Doctors news. Online document at: www.doctorsnews.co.kr/news/articleView.html?idxno=108026, accessed August23, 2018.
5.
SongSC. Professors of Korean medicine acknowledge the main cause of liver injury to be herbal medicine. Doctors news. Online document at: www.doctorsnews.co.kr/news/articleView.html?idxno=102753, accessed August17, 2018.
6.
SongSC. Herbal medicine intake in pregnancy is a threat to fetal health. Doctors news. Online document at: www.doctorsnews.co.kr/news/articleView.html?idxno=86471, accessed August17, 2018.
7.
LeeHS. “Side effects of herbal medicine experienced” by 87.1%. Doctors news. Online document at: www.doctorsnews.co.kr/news/articleView.html?idxno=31776, accessed August17, 2018.
8.
LeeSY. Dangerous Korean medicine… How long will this situation be neglected? Doctors news. Online document at: www.doctorsnews.co.kr/news/articleView.html?idxno=67235, accessed August17, 2018.
9.
KimDJ. A preliminary multicenter study for the detection of toxic hepatitis induced by various plant preparations and healthy foods and the development of nationwide reporting system of toxic hepatitis. KFDA Report, 2003:1–26.
10.
KimDJ. A Multicenter Study for the Detection and the Development of Nationwide Reporting System of Toxic Liver Injury. The Annual Report of Korea National Toxicology Program 2005. Seoul: National Institute of Toxicological Research, 2006:477–481.
11.
DevarbhaviH. An update on drug-induced liver injury. J Clin Exp Hepatol, 2012; 2:247–259.
12.
TeschkeR, WolffA, FrenzelC, et al.Drug and herb induced liver injury: Council for International Organizations of Medical Sciences scale for causality assessment. World J Hepatol, 2014; 6:17–32.
13.
EypaschE, LeferingR, KumCK, TroidlH. Probability of adverse events that have not yet occurred: A statistical reminder. BMJ, 1995; 311:619–620.
14.
SukKT, KimDJ, KimCH, et al.A prospective nationwide study of drug-induced liver injury in Korea. Am J Gastroenterol, 2012; 107:1380–1387.
15.
SgroC, ClinardF, OuazirK, et al.Incidence of drug-induced hepatic injuries: A French population-based study. Hepatology, 2002; 36:451–455.
16.
BjornssonES, BergmannOM, BjornssonHK, et al.Incidence, presentation, and outcomes in patients with drug-induced liver injury in the general population of Iceland. Gastroenterology, 2013; 144:1419–1425, 1425.e1–e3; quiz e19–e20.
17.
YoonGJ. The Use and Perception of Koreans on Korean Medicine. Health and Welfare Issue & Focus. Seoul: Korea Institute for Health and Social Affairs, 2012; 140:1–8.
18.
ChoiBH, SonCH, LimBM. The relationship between the use of Korean and Western Medicine in treating musculoskeletal disease. J Korean Med, 2014; 35:22–31.
TakikawaH. Recent status of drug-induced liver injury and its problems in Japan. JMAJ, 2010; 53:243–247.
21.
DananG, TeschkeR. RUCAM in drug and herb induced liver injury: The update. Int J Mol Sci, 2015; 17:14.
22.
MelchartD, HagerS, AlbrechtS, et al.Herbal Traditional Chinese Medicine and suspected liver injury: A prospective study. World J Hepatol, 2017; 9:1141–1157.
23.
AithalGP, WatkinsPB, AndradeRJ, et al.Case definition and phenotype standardization in drug-induced liver injury. Clin Pharmacol Ther, 2011; 89:806–815.
24.
ChoJH, OhDS, HongSH, et al.A nationwide study of the incidence rate of herb-induced liver injury in Korea. Arch Toxicol, 2017; 91:4009–4015.
25.
TeschkeR, SchwarzenboeckA, FrenzelC, et al.The mystery of the Hawaii liver disease cluster in summer 2013: A pragmatic and clinical approach to solve the problem. Ann Hepatol, 2016; 15:91–109.
26.
TeschkeR, EickhoffA. The Honolulu liver disease cluster at the Medical Center: Its mysteries and challenges. Int J Mol Sci, 2016; 17:476.
27.
TeschkeR, WolffA, EickhoffA, DananG. Is obesity rather than the dietary supplement used for weight reduction the cause of liver injury?. J Gastroenterol Hepatol Open, 2018; 2:152–157.
28.
WillsonC. Dietary supplements containing Aegeline and DMAA (1,3-Dimethylamylamine) and their role in liver injury. Int J Med Res Health Sci, 2018; 7:10–35.
